Multimodal imaging of the role of hyperglycemia following experimental subarachnoid hemorrhage

Ana Joya,Sandra Plaza-García,Daniel Padro,Laura Aguado,Leyre Iglesias,Maider Garbizu,Vanessa Gómez-Vallejo,Carlos Laredo,Unai Cossío,Ramon Torné,Sergio Amaro,Anna M Planas,Jordi Llop,Pedro Ramos-Cabrer,Carles Justicia,Abraham Martín
DOI: https://doi.org/10.1177/0271678X231197946
Abstract:Hyperglycemia has been linked to worsening outcomes after subarachnoid hemorrhage (SAH). Nevertheless, the mechanisms involved in the pathogenesis of SAH have been scarcely evaluated so far. The role of hyperglycemia was assessed in an experimental model of SAH by T2 weighted, dynamic contrast-enhanced magnetic resonance imaging (T2W and DCE-MRI), [18F]BR-351 PET imaging and immunohistochemistry. Measures included the volume of bleeding, the extent of cerebral infarction and brain edema, blood brain barrier disruption (BBBd), neutrophil infiltration and matrix metalloprotease (MMP) activation. The neurofunctional outcome, neurodegeneration and myelinization were also investigated. The induction of hyperglycemia increased mortality, the size of the ischemic lesion, brain edema, neurodegeneration and worsened neurological outcome during the first 3 days after SAH in rats. In addition, these results show for the first time the exacerbating effect of hyperglycemia on in vivo MMP activation, Intercellular Adhesion Molecule 1 (ICAM-1) expression and neutrophil infiltration together with increased BBBd, bleeding volume and fibrinogen accumulation at days 1 and 3 after SAH. Notably, these data provide valuable insight into the detrimental effect of hyperglycemia on early BBB damage mediated by neutrophil infiltration and MMP activation that could explain the worse prognosis in SAH.
What problem does this paper attempt to address?